26-A-19859-ACC HS235, A NEXT-GENERATION BMP-9/-10-SPARING ACTIVIN SIGNALING INHIBITOR FOR THE TREATMENT OF PULMONARY HYPERTENSION (PH) AND HEART FAILURE: RESULTS FROM A PHASE 1 HEALTHY VOLUNTEER TRIAL DEMONSTRATING FAVOURABLE SAFETY AND PHARMACODYNAMIC EFFECTS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Pulmonary Hypertension Research and Treatments
TGF-β signaling in diseases
Cardiac Fibrosis and Remodeling
Publication details
- Journal / source
- Journal of the American College of Cardiology
- Volume
- 87
- Issue
- 13
- Pages
- A967–A967
- Publication date
- 27 March 2026
- Language
- EN